Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026)
Pro Dex's (PDEX) quarterly Cash from Financing Activities came in at $5.5 million in Q1 2026, up 183.59% year-on-year from $1.9 million in Q1 2025, and up 209.22% quarter-over-quarter from -$5.0 million in Q4 2025.
Pro Dex (PDEX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Pro Dex has disclosed Cash from Financing Activities across 15 years of filings, most recently posting $5.5 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $5.5 million, up 183.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.5 million (down 524.37% YoY), and the FY2025 annual result was -$292000.0, up 93.2% from the prior year.
- Cash from Financing Activities came in at $5.5 million for Q1 2026 at Pro Dex, up from -$5.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $5.5 million in Q1 2026 to a low of -$5.0 million in Q4 2025.
- The 5-year median for Cash from Financing Activities is -$853000.0 (2022), against an average of -$486235.3.
- Peak annual rise in Cash from Financing Activities reached 200.54% in 2024, while the deepest fall reached 509.12% in 2024.
- Pro Dex's Cash from Financing Activities stood at -$1.5 million in 2022, then jumped by 136.88% to $558000.0 in 2023, then surged by 200.54% to $1.7 million in 2024, then slumped by 398.21% to -$5.0 million in 2025, then soared by 209.22% to $5.5 million in 2026.
- The last three Cash from Financing Activities figures came in at $5.5 million (Q1 2026), -$5.0 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Pro Dex | 200.16 Mn | 192.54 Mn | 6.13 Mn | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 558,000.00 |
| Dec 31, 2023 | 558,000.00 |